)
Visual
test
Prestige Consumer Healthcare
Prestige Consumer Healthcare (PBH) investor relations material
Prestige Consumer Healthcare Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary5 Feb, 2026
Executive summary
Q3 revenue was $283.4 million, down 2.4% year-over-year but slightly above forecast, with net income at $46.7 million and adjusted EPS at $1.14, reflecting ongoing supply constraints in Eye & Ear Care.
Free cash flow year-to-date rose to $208.8 million, up 12.9% versus prior year, supporting capital allocation flexibility.
The Pillar5 Pharma acquisition for over $110 million was completed in December, enhancing internal supply for Clear Eyes.
Significant share repurchases totaled $155.6 million for the first nine months, nearly 5% of shares outstanding.
The company maintained confidence in its core business and expects continued free cash flow growth for the fiscal year.
Financial highlights
Q3 revenue was $283.4 million, a 2.4% decrease year-over-year, mainly due to Clear Eyes supply constraints.
Adjusted EBITDA margin remained in the low 30s; adjusted diluted EPS was $1.14, down from $1.22 last year.
Gross margin for Q3 was 55.5%, nearly flat year-over-year.
Operating income for Q3 was $82.5 million, down from $92.0 million prior year.
Free cash flow for nine months was $208.8 million, up from $184.9 million year-over-year.
Outlook and guidance
Fiscal 2026 revenue outlook narrowed to approximately $1.1 billion, reflecting a 3% year-over-year decrease.
Adjusted diluted EPS for the year expected to be about $4.54; free cash flow guidance maintained at $245 million or more.
Sequential improvement in Clear Eyes supply anticipated in Q4 and beyond.
Q4 gross margin expected at 57%; full-year G&A just over 10% of sales.
Management expects continued volatility due to global supply chain constraints, inflation, and changing consumer purchasing patterns.
Quantify Clear Eyes supply constraint revenue impact
Elaborate on challenging consumer environment factors
Explain the supplier loan write-off circumstances
When will Clear Eyes supply fully normalize?
What drives current share repurchase levels?
How long will channel shifts impact sales?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 7 FebGICRE
Net profit for the nine months surged to ₹6,62,217 lakhs, with a robust solvency ratio of 3.87. - 7 Feb517271
Strong revenue and profit growth, interim dividend, and major investments approved. - 7 Feb514167
Quarterly and nine-month results reflect solid revenue, profit, and compliance with new labour codes. - 7 FebMGL
Strong revenue growth offset by lower margins and profit; interim dividend declared. - 7 FebPGIL
Strong revenue and margin growth, with India set for further expansion and upgraded ratings. - 7 Feb504614
Strong revenue and profit growth in Q3 FY26, led by power and steel segments. - 7 FebCHEMPLASTS
Net losses widened and revenue fell year-over-year amid regulatory and market headwinds. - 7 FebSBIN
Q3 FY26 net profit reached ₹21,028.15 crore, driven by robust income and strategic divestments. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus.
Next Prestige Consumer Healthcare earnings date
Q4 20268 May, 2026
Prestige Consumer Healthcare
Next Prestige Consumer Healthcare earnings date
Q4 20268 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Prestige Consumer Healthcare Inc is a U.S.-based company that markets and distributes over-the-counter healthcare products. Its product categories include pain relief, digestive health, eye care, and feminine hygiene. The company’s brands are available through retail, online, and pharmacy channels. The company is headquartered in Tarrytown, New York, and its shares are listed on the NYSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage